Rocephin (ceftriaxone) is now approved for acute otitis media
February 1998
Rocephin (ceftriaxone) is now approved for acute otitis media. It's the first SINGLE-DOSE antibiotic approved for this use.
A single IM injection of Rocephin works about as well as 10 days of oral amoxicillin...TMP/SMX (Septra, etc)...or cefaclor (Ceclor). But it's LESS effective than 10 days of Augmentin.
Side effects with Rocephin are similar to using oral antibiotics...usually diarrhea and rash.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote